Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study

Go back to Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 3.57 +0.30 (9.17%)
Previous Close $3.27    52 Week High $9.58 
Open $3.40    52 Week Low $2.34 
Day High $3.69    P/E N/A 
Day Low $3.20    EPS $-0.34 
Volume 1,985,336